• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对大肠杆菌性腹泻的T4噬菌体:潜力与问题

T4 phages against Escherichia coli diarrhea: potential and problems.

作者信息

Denou Emmanuel, Bruttin Anne, Barretto Caroline, Ngom-Bru Catherine, Brüssow Harald, Zuber Sophie

机构信息

Nestlé Research Center, Nestec Ltd, Lausanne 26, Switzerland.

出版信息

Virology. 2009 May 25;388(1):21-30. doi: 10.1016/j.virol.2009.03.009. Epub 2009 Apr 1.

DOI:10.1016/j.virol.2009.03.009
PMID:19339031
Abstract

A combination of in vitro and in vivo experiments with comparative phage genomics was used for the rational design of a phage cocktail against E. coli diarrhea. Orally applied T4 coliphages representing three different subgroups (T4-, RB49- and JS98-like phages) had no negative impact on the murine gut microbiota. T4 phages were found with high titers in the cecum and colon and lower titers in the small intestine, but were not detected in the blood, liver or spleen. No adverse effects were observed after one-month exposure to phage nor were serum anti-T4 antibodies detected. T4 phages belonging to the same subgroup showed closely related genomes that differed by 12 (phage JS10 vs. JS98 reference) to 17 (phage JSE vs. RB49 reference) insertion/deletions mostly representing single small ORFs. Bioinformatic analysis did not reveal undesired genes in the T4 genomes. Sequence variability was seen over the tail fibre genes, but the variability did not correlate with phage host range. The investigated T4 phages were not only species- but also strain-specific, necessitating the use of phage cocktails consisting of 10 and 16 T4 phage isolates to cover half to two thirds of E. coli strains representing the five main pathotypes isolated from diarrhea patients.

摘要

结合体外和体内实验以及比较噬菌体基因组学,对针对大肠杆菌腹泻的噬菌体鸡尾酒进行了合理设计。口服的代表三种不同亚组(T4样、RB49样和JS98样噬菌体)的T4大肠杆菌噬菌体对小鼠肠道微生物群没有负面影响。在盲肠和结肠中发现T4噬菌体的滴度较高,在小肠中滴度较低,但在血液、肝脏或脾脏中未检测到。暴露于噬菌体一个月后未观察到不良反应,也未检测到血清抗T4抗体。属于同一亚组的T4噬菌体显示出密切相关的基因组,它们之间存在12个(噬菌体JS10与JS98参考株相比)到17个(噬菌体JSE与RB49参考株相比)插入/缺失,大多代表单个小开放阅读框。生物信息学分析未在T4基因组中发现不良基因。在尾丝基因上观察到序列变异性,但这种变异性与噬菌体宿主范围无关。所研究的T4噬菌体不仅具有种特异性,还具有菌株特异性,因此需要使用由10种和16种T4噬菌体分离株组成的噬菌体鸡尾酒,以覆盖代表从腹泻患者中分离出的五种主要致病型的一半至三分之二的大肠杆菌菌株。

相似文献

1
T4 phages against Escherichia coli diarrhea: potential and problems.针对大肠杆菌性腹泻的T4噬菌体:潜力与问题
Virology. 2009 May 25;388(1):21-30. doi: 10.1016/j.virol.2009.03.009. Epub 2009 Apr 1.
2
Genome analysis of phage JS98 defines a fourth major subgroup of T4-like phages in Escherichia coli.噬菌体JS98的基因组分析确定了大肠杆菌中T4样噬菌体的第四个主要亚群。
J Bacteriol. 2007 Nov;189(22):8206-14. doi: 10.1128/JB.00838-07. Epub 2007 Aug 10.
3
Isolation of Escherichia coli bacteriophages from the stool of pediatric diarrhea patients in Bangladesh.从孟加拉国小儿腹泻患者粪便中分离大肠杆菌噬菌体。
J Bacteriol. 2004 Dec;186(24):8287-94. doi: 10.1128/JB.186.24.8287-8294.2004.
4
In vitro and in vivo bacteriolytic activities of Escherichia coli phages: implications for phage therapy.大肠杆菌噬菌体的体外和体内溶菌活性:对噬菌体疗法的启示
Antimicrob Agents Chemother. 2004 Jul;48(7):2558-69. doi: 10.1128/AAC.48.7.2558-2569.2004.
5
Oral Phage Therapy of Acute Bacterial Diarrhea With Two Coliphage Preparations: A Randomized Trial in Children From Bangladesh.两种大肠杆菌噬菌体制剂用于急性细菌性腹泻的口服噬菌体治疗:在孟加拉国儿童中的一项随机试验
EBioMedicine. 2016 Jan 5;4:124-37. doi: 10.1016/j.ebiom.2015.12.023. eCollection 2016 Feb.
6
In vivo replication of T4 and T7 bacteriophages in germ-free mice colonized with Escherichia coli.T4和T7噬菌体在定殖有大肠杆菌的无菌小鼠体内的复制
Virology. 2009 Oct 10;393(1):16-23. doi: 10.1016/j.virol.2009.07.020. Epub 2009 Aug 21.
7
Coverage of diarrhoea-associated Escherichia coli isolates from different origins with two types of phage cocktails.用两种噬菌体鸡尾酒对不同来源的腹泻相关大肠杆菌分离株进行覆盖。
Microb Biotechnol. 2014 Mar;7(2):165-76. doi: 10.1111/1751-7915.12113.
8
Plasticity of the gene functions for DNA replication in the T4-like phages.T4 样噬菌体中 DNA 复制基因功能的可塑性。
J Mol Biol. 2006 Aug 4;361(1):46-68. doi: 10.1016/j.jmb.2006.05.071. Epub 2006 Jun 16.
9
Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy.口服大肠杆菌噬菌体T4的人类志愿者:噬菌体疗法的安全性测试。
Antimicrob Agents Chemother. 2005 Jul;49(7):2874-8. doi: 10.1128/AAC.49.7.2874-2878.2005.
10
T-even-related bacteriophages as candidates for treatment of Escherichia coli urinary tract infections.作为治疗大肠杆菌尿路感染候选药物的T偶数相关噬菌体
Arch Virol. 2008;153(3):507-15. doi: 10.1007/s00705-007-0031-4. Epub 2008 Jan 8.

引用本文的文献

1
Insight into Bacteriophage Therapy for Bacterial Infections and Cancer.对噬菌体疗法治疗细菌感染和癌症的见解。
Mol Biotechnol. 2025 Jul 9. doi: 10.1007/s12033-025-01466-w.
2
Treatment of Infections with T4-Related Bacteriophages Belonging to Class : Selecting Phage on the Basis of Their Generalized Transduction Capability.属于类的T4相关噬菌体感染的治疗:基于其广义转导能力选择噬菌体
Viruses. 2025 May 14;17(5):701. doi: 10.3390/v17050701.
3
Beyond Antibiotics: Exploring the Potential of Bacteriophages and Phage Therapy.超越抗生素:探索噬菌体及噬菌体疗法的潜力
Phage (New Rochelle). 2024 Dec 18;5(4):186-202. doi: 10.1089/phage.2024.0005. eCollection 2024 Dec.
4
Characterization and genomic analysis of the lytic bacteriophage vB_EclM_HK6 as a potential approach to biocontrol the spread of Enterobacter cloacae contaminating food.肠杆菌噬菌体 vB_EclM_HK6 的特性及其基因组分析,有望成为控制污染食品的阴沟肠杆菌传播的生物防治方法。
BMC Microbiol. 2024 Oct 15;24(1):408. doi: 10.1186/s12866-024-03541-9.
5
Antimicrobial resistance: use of phage therapy in the management of resistant infections.抗菌药物耐药性:噬菌体疗法在耐药感染治疗中的应用。
Mol Biol Rep. 2024 Aug 21;51(1):925. doi: 10.1007/s11033-024-09870-2.
6
Optimized Dosing and Delivery of Bacteriophage Therapy for Wound Infections.伤口感染噬菌体疗法的优化剂量与给药方式
bioRxiv. 2024 Aug 25:2024.05.07.593005. doi: 10.1101/2024.05.07.593005.
7
The untapped potential of phage model systems as therapeutic agents.噬菌体模型系统作为治疗剂的未开发潜力。
Virus Evol. 2024 Jan 13;10(1):veae007. doi: 10.1093/ve/veae007. eCollection 2024.
8
Microfluidics: Insights into Intestinal Microorganisms.微流控技术:对肠道微生物的见解
Microorganisms. 2023 Apr 27;11(5):1134. doi: 10.3390/microorganisms11051134.
9
Single-arm, open-labelled, safety and tolerability of intrabronchial and nebulised bacteriophage treatment in children with cystic fibrosis and .单臂、开放标签、支气管内和雾化噬菌体治疗囊性纤维化儿童的安全性和耐受性。
BMJ Open Respir Res. 2023 May;10(1). doi: 10.1136/bmjresp-2022-001360.
10
Characterization of a lytic phage CE1 and its potential use in therapy against avian pathogenic infections.一种裂解性噬菌体CE1的特性及其在治疗禽致病性感染中的潜在用途。
Front Microbiol. 2023 Feb 16;14:1091442. doi: 10.3389/fmicb.2023.1091442. eCollection 2023.